[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Research Letter
February 14, 2019

Trends in Smoking and e-Cigarette Use Among US Patients With Cancer, 2014-2017

Author Affiliations
  • 1Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas
  • 2Division of Biostatistics, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas
  • 3Department of Statistical Science, Southern Methodist University, Dallas, Texas
  • 4Department of Radiation Oncology, Brigham and Women’s Hospital, Boston, Massachusetts
  • 5Dana-Farber Cancer Institute, McGraw/Patterson Center for Population Sciences, Boston, Massachusetts
JAMA Oncol. 2019;5(3):426-428. doi:10.1001/jamaoncol.2018.6858

Electronic cigarettes (e-cigarettes) have become increasingly popular in the United States1 and are advertised as a potentially safe and useful method of smoking cessation, despite unknown long-term health sequelae.2,3 Individuals with cancer are particularly sensitive to the harms of active smoking, thus smoking cessation is a critical component of cancer survivorship.4 However, the patterns and implications of e-cigarette use in patients with cancer are not well known. Therefore, we examined contemporary trends of conventional smoking and e-cigarette use among patients with cancer.